Targeted therapy for human epidermal growth factor receptor 2-positive breast Cancer: Can there be too many active drugs? Editorial Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Breast Neoplasms
  • Drug Resistance, Neoplasm
  • Molecular Targeted Therapy

publication date

  • August 10, 2011

Research

keywords

  • Editorial

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.36.4091

PubMed ID

  • 21730267

Additional Document Info

start page

  • 3111

end page

  • 3

volume

  • 29

number

  • 23